Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment.
Department of Surgery, Hospital of University of Pennsylvania, Philadelphia 19104.
J H
JH
Roark
A M
AM
Posselt
L
L
Campos
J
J
Kim
K D
KD
Chavin
J S
JS
Bromberg
C F
CF
Barker
A
A
Naji
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D018801:CD2 Antigens; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011920:Rats, Inbred WF; D011971:Receptors, Immunologic / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D011971:Receptors, Immunologic